Introduction
Dengue fever and chikungunya are arboviral diseases transmitted by Aedes mosquitoes. Unlike dengue, chikungunya typically consists of a self-limiting and nonfatal acute illness characterised by fever, rash and incapacitating arthralgia [1] .
Case report
In November 2006, a 70-year old man presented with a history of high fever, severe headache and arthralgia of knees, and small joints of his hands and feet of 3 days' duration. On examination, the patient had mild swelling of the small joints of hands. There was no skin rash, bleeding into skin or mucosal membranes. His blood analysis showed a leucopenia (WBC 3.04 x 103 per µl) with a relative lymphocytosis (51%). The total platelet count was 115 x 103 per µl. The haemoglobin was 14.3 g / dl with a packed cell volume of 43.8%. The first-hour erythrocyte sedimentation rate, serum alanine transaminase level and urine analysis were normal.
As it was difficult to differentiate between dengue fever and chikungunya, polymerase chain reaction (PCR) was used to confirm the aetiology. Viral RNA was extracted from serum samples using QiAmp Viral RNA Kits (Qiagen Inc., USA). Reverse transcription-PCR (RT-PCR) protocols were used to amplify dengue [2, 3] and chikungunya [4] viruses respectively. RT-PCR confirmed the presence of both dengue and chikungunya viruses in the patient's serum (figure 1).
Comment
This is the first case report of chikungunya and dengue co-infection confirmed by molecular assays in Sri Lanka. As the clinical and biochemical manifestations of this case were suggestive of both dengue fever and chikungunya, early aetiological confirmation was important as delayed diagnosis of dengue could result in fatal complications.
Laboratory confirmation of dengue and chikungunya can be made by several methods. One of the widely used 
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